Sobre Xingxu Kangda

Especializados en jeringas de seguridad retráctiles

Shaanxi Xingxukangda Medical Technology desarrolla y fabrica jeringas de seguridad retráctiles estériles y soluciones automatizadas relacionadas.

杏旭康达 XINGXU KANGDA

Perfil de empresa

Capacidad de fabricación detrás de cada producto

Xingxu Medical Devices (Suzhou) se estableció en 2016. En 2023 se creó una operación de fabricación en Lintong, Shaanxi, enfocada en el desarrollo y la producción de jeringas de seguridad.

La operación integra I+D, moldes de precisión, montaje automatizado, diseño de procesos limpios y suministro B2B internacional.

2016Operación de Suzhou establecida
2023Fábrica de Shaanxi establecida
2026Cooperación B2B global

Integrated company scope

Product, tooling and automation developed around one safety platform

Xingxu Kangda brings several connected capabilities together around retractable safety syringe development and manufacturing.

01

Product development

Product structures are developed around controlled manual needle retraction and single-use disablement.

02

Precision tooling

Mold development supports the geometry and repeatability required by syringe components.

03

Automation engineering

Assembly equipment and process design connect product development with scalable manufacturing.

04

International B2B support

Product information, videos and available documents support distributor and institutional evaluation.

Working principles

A professional basis for long-term B2B communication

The company profile is strengthened by showing how technical and commercial discussions are approached.

01

Be specific

Product conversations begin with structure, capacity, needle specification and intended market.

02

Show the evidence

Available product videos, certificates and patent documents are presented for direct review.

03

Keep communication direct

Buyers can reach the product team through the inquiry form, email or WhatsApp.

Public records in China

Company development reflected in public sources

The following milestones link to Chinese corporate, media and regulatory records. Planned capacity and project figures are presented as reported at the time, not as current supply commitments.

WA